InvestorsHub Logo
Followers 283
Posts 1162
Boards Moderated 0
Alias Born 10/04/2020

Re: None

Monday, 03/01/2021 8:20:35 AM

Monday, March 01, 2021 8:20:35 AM

Post# of 198358
A New Era In Pharmaceuticals Has Arrived-The Evolution of Monoclonal Abs

https://www.ipwatchdog.com/2018/10/08/evolution-antibody-patents/id=101971/

The Key "take aways" of this article:

1). Last year the best-selling pharmaceutical worldwide was derived from a Monoclonal Antibody.

2). Seven (7) of the 20 best-selling pharmaceuticals in the world today are therapeutics derived from monoclonal antibodies for treating a wide range of conditions including rheumatoid arthritis, autoimmune diseases, and various cancers.

3). These Monoclonal Antibody based drugs are generating Billions of Dollars in pharmaceutical sales annually.

4). Monoclonal Antibodies are expected to become more valuable in the years to come.

I would say this sheds a great deal of light on what we have with ENZC!

The following is from the Playbook "Marketing 101"

If anyone knows anything about how fortunes are made it's about "Market Timing" i.e. being positioned in front of a Trend BEFORE it explodes in the market place and/or those Companies that jump on the Trend in its early stages as its taking off! This explains companies like Microsoft, Apple, Google, Amazon, Netflix, etc.

Get the picture???

Well, THAT'S US!!!

Can I get an AMEN!!!

Be well and prosper...